12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

ProQuad regulatory update

EMA's CHMP issued a positive opinion recommending approval of a label expansion for ProQuad from Sanofi Pasteur MSD to include children from 9 months of age under special circumstances, such...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >